# Efficacy and Safety Evaluation of Ruscus Aculeatus L in Patients With Hemorrhoids

> **NCT07128979** · PHASE4 · RECRUITING · sponsor: **Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey** · enrollment: 250 (estimated)

## Conditions studied

- Hemorrhoid

## Interventions

- **DRUG:** Neoven 225 mg capsules
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07128979
- **Lead sponsor:** Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2026-08-01
- **Final completion:** 2026-11-02
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2025-08-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07128979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07128979, "Efficacy and Safety Evaluation of Ruscus Aculeatus L in Patients With Hemorrhoids". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07128979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*